These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 29444938)

  • 1. Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes.
    Jegaskanda S; Mason RD; Andrews SF; Wheatley AK; Zhang R; Reynoso GV; Ambrozak DR; Santos CP; Luke CJ; Matsuoka Y; Brenchley JM; Hickman HD; Talaat KR; Permar SR; Liao HX; Yewdell JW; Koup RA; Roederer M; McDermott AB; Subbarao K
    J Virol; 2018 May; 92(9):. PubMed ID: 29444938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemagglutinin head-specific responses dominate over stem-specific responses following prime boost with mismatched vaccines.
    Jegaskanda S; Andrews SF; Wheatley AK; Yewdell JW; McDermott AB; Subbarao K
    JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31723058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.
    Rudenko L; Naykhin A; Donina S; Korenkov D; Petukhova G; Isakova-Sivak I; Losev I; Stukova M; Erofeeva M; Nikiforova A; Power M; Flores J
    Hum Vaccin Immunother; 2015; 11(12):2839-48. PubMed ID: 26697973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine.
    Babu TM; Levine M; Fitzgerald T; Luke C; Sangster MY; Jin H; Topham D; Katz J; Treanor J; Subbarao K
    Vaccine; 2014 Nov; 32(50):6798-804. PubMed ID: 25446831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A live attenuated H5N2 prime- inactivated H5N1 boost vaccination induces influenza virus hemagglutinin stalk specific antibody responses.
    Kongchanagul A; Samnuan K; Wirachwong P; Surichan S; Puthavathana P; Pitisuttithum P; Boonnak K
    Vaccine; 2020 Jan; 38(4):852-858. PubMed ID: 31708176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral priming with replicating adenovirus serotype 4 followed by subunit H5N1 vaccine boost promotes antibody affinity maturation and expands H5N1 cross-clade neutralization.
    Khurana S; Coyle EM; Manischewitz J; King LR; Ishioka G; Alexander J; Smith J; Gurwith M; Golding H
    PLoS One; 2015; 10(1):e0115476. PubMed ID: 25629161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.
    Matsuoka Y; Suguitan A; Orandle M; Paskel M; Boonnak K; Gardner DJ; Feldmann F; Feldmann H; Marino M; Jin H; Kemble G; Subbarao K
    J Virol; 2014 Jul; 88(14):8139-52. PubMed ID: 24807726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
    Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial.
    Pitisuttithum P; Boonnak K; Chamnanchanunt S; Puthavathana P; Luvira V; Lerdsamran H; Kaewkungwal J; Lawpoolsri S; Thanachartwet V; Silachamroon U; Masamae W; Schuetz A; Wirachwong P; Thirapakpoomanunt S; Rudenko L; Sparrow E; Friede M; Kieny MP
    Lancet Infect Dis; 2017 Aug; 17(8):833-842. PubMed ID: 28533093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
    Leroux-Roels I; Roman F; Forgus S; Maes C; De Boever F; Dramé M; Gillard P; van der Most R; Van Mechelen M; Hanon E; Leroux-Roels G
    Vaccine; 2010 Jan; 28(3):849-57. PubMed ID: 19835828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.
    Talaat KR; Luke CJ; Khurana S; Manischewitz J; King LR; McMahon BA; Karron RA; Lewis KD; Qin J; Follmann DA; Golding H; Neuzil KM; Subbarao K
    J Infect Dis; 2014 Jun; 209(12):1860-9. PubMed ID: 24604819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines.
    Cheng X; Eisenbraun M; Xu Q; Zhou H; Kulkarni D; Subbarao K; Kemble G; Jin H
    PLoS One; 2009; 4(2):e4436. PubMed ID: 19209231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
    Ghorbani A; Ngunjiri JM; Xia M; Elaish M; Jang H; Mahesh KC; Abundo MC; Jiang X; Lee CW
    Vaccine; 2019 Feb; 37(10):1356-1364. PubMed ID: 30691981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization.
    Khurana S; Coyle EM; Dimitrova M; Castellino F; Nicholson K; Del Giudice G; Golding H
    PLoS One; 2014; 9(4):e95496. PubMed ID: 24755693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains.
    Wang J; Li D; Perry S; Hilchey SP; Wiltse A; Treanor JJ; Sangster MY; Zand MS
    mBio; 2021 Aug; 12(4):e0044921. PubMed ID: 34225490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immune responses elicited by an intranasal inactivated H5 influenza vaccine.
    Ainai A; van Riet E; Ito R; Ikeda K; Senchi K; Suzuki T; Tamura SI; Asanuma H; Odagiri T; Tashiro M; Kurata T; Multihartina P; Setiawaty V; Pangesti KNA; Hasegawa H
    Microbiol Immunol; 2020 Apr; 64(4):313-325. PubMed ID: 31957054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
    Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
    Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets.
    Suguitan AL; Cheng X; Wang W; Wang S; Jin H; Lu S
    PLoS One; 2011; 6(7):e21942. PubMed ID: 21760928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of in vitro cross-reactivity to avian H5N1 and pandemic H1N1 2009 influenza following prime boost regimens of seasonal influenza vaccination in healthy human subjects: a randomised trial.
    Bethell D; Saunders D; Jongkaewwattana A; Kramyu J; Thitithayanont A; Wiboon-ut S; Yongvanitchit K; Limsalakpetch A; Kum-Arb U; Uthaimongkol N; Garcia JM; Timmermans AE; Peiris M; Thomas S; Engering A; Jarman RG; Mongkolsirichaikul D; Mason C; Khemnu N; Tyner SD; Fukuda MM; Walsh DS; Pichyangkul S
    PLoS One; 2013; 8(3):e59674. PubMed ID: 23555741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.
    Fan S; Gao Y; Shinya K; Li CK; Li Y; Shi J; Jiang Y; Suo Y; Tong T; Zhong G; Song J; Zhang Y; Tian G; Guan Y; Xu XN; Bu Z; Kawaoka Y; Chen H
    PLoS Pathog; 2009 May; 5(5):e1000409. PubMed ID: 19412338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.